Paeoniflorin attenuates cisplatin induced ototoxicity by inhibiting ferroptosis mediated by HMGB1/NRF2/GPX4 pathway
Food and Chemical Toxicology · 2025
DOI: 10.1016/j.fct.2025.115550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025. Verfasst von Shaoli Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Med…. Hauptthemen laut MEDLINE: Cisplatin, Ferroptosis, HMGB1 Protein, NF-E2-Related Factor 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Cisplatin-induced ototoxicity is a major dose-limiting complication in cancer therapy, profoundly diminishing quality of life. Paeoniflorin (PAE), a bioactive compound from Paeonia lactiflora, exhibits diverse pharmacological activities. This study aimed to evaluate the efficacy of PAE in countering cisplatin-induced ototoxicity and explore its molecular mechanisms. Cochlear hair cell injury models were established both in vitro and in vivo using cisplatin. Ferroptosis was induced in HEI-OC1 cells with RSL3, and HMGB1-overexpressing models were constructed to investigate its role. The findings indicated that PAE effectively alleviated cisplatin-induced hearing loss and cochlear cell damage in both in vitro and in vivo models. Moreover, PAE significantly mitigated the inflammatory response triggered by cisplatin exposure. Mechanistically, PAE reduced oxidative stress and ferroptosis by upregulating nuclear factor erythroid 2-related factor 2 (NRF2), solute carrier family 7 member 11 (SLC7A11), and glutathione peroxidase 4 (GPX4). Notably, PAE directly interacted with HMGB1 and suppressed its expression, thereby inhibiting HMGB1-mediated ferroptosis in cochlear cells. This study highlights PAE as a promising therapeutic candidate for preventing cisplatin-induced ototoxicity. By elucidating the role of PAE in modulating ferroptosis through HMGB1 and the NRF2/SLC7A11/GPX4 pathway, our findings provide new insights into potential strategies for mitigating cisplatin-induced hearing loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: chaini7@126.com.
Förderung
- Shanghai Municipal Health Commission
Zitieren
APA
Chen, S., Zheng, W., Wang, Y., Zhao, X., Deng, W., & Chai, N. (2025). Paeoniflorin attenuates cisplatin induced ototoxicity by inhibiting ferroptosis mediated by HMGB1/NRF2/GPX4 pathway. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2025.115550
Vancouver
Chen S, Zheng W, Wang Y, Zhao X, Deng W, Chai N. Paeoniflorin attenuates cisplatin induced ototoxicity by inhibiting ferroptosis mediated by HMGB1/NRF2/GPX4 pathway. Food and Chemical Toxicology. 2025. doi:10.1016/j.fct.2025.115550
BibTeX
@article{Chen2025,
author = {Chen, Shaoli and Zheng, Wei and Wang, Yichao and Zhao, Xinyu and Deng, Wenhao and Chai, Ni},
title = {Paeoniflorin attenuates cisplatin induced ototoxicity by inhibiting ferroptosis mediated by HMGB1/NRF2/GPX4 pathway},
journal = {Food and Chemical Toxicology},
year = {2025},
doi = {10.1016/j.fct.2025.115550}
}
EUVIMED